KAYA
|
|
| BOM : 539276 NSE : KAYA | |
| LT :
Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive] Debt : High |
Updated: |
| ST :
Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward Pledged Shares : None or < 25% |
Jun 10,2025 |
|
Price(EOD): ₹ 342.05
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Hospital & Healthcare Services |
| MCap: ₹ 448.09 Cr | |
| Industry Peers & Returns | 1W | 1M | 1Y |
| KAYA | 4.3% | 33.2% | 13.9% |
| MAX HEALTHCARE INSTITUTE | 3% | 1.8% | 45.5% |
| APOLLO HOSPITALS ENTERPRISE | 0.9% | -0% | 16.8% |
| FORTIS HEALTHCARE | 5.5% | 15.1% | 73% |
| GLOBAL HEALTH | 0.2% | -2.4% | 6.7% |
| NARAYANA HRUDAYALAYA | 4.3% | 1.8% | 51% |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES | -2.5% | -0.2% | 72.5% |
| DR LAL PATHLABS | 4% | 5.2% | 3.6% |
| ASTER DM HEALTHCARE | -2.3% | 3.9% | 68.8% |
FUNDAMENTAL ANALYSIS OF KAYA
[ Q(TTM): Mar2025, Y: Mar2024
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF KAYA
[As on : Jun 10,2025
]
| Ratio | Consolidated | |
|---|---|---|
|
P/E P/B P/S |
-11.45
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs -39.13 Cr
[Latest Qtr - Mar2025 - Consolidated Results ] -1.96
P/B Calculated based on Book Value of Rs -228.54 Cr
[Latest Year - Mar2024 - Consolidated Results ] 1.98
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 226.36 Cr
[Latest Qtr - Mar2025 - Consolidated Results ] |
|
| Financial Ratios → | ||
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
24% 60% 14% |
SHARE PRICE MOMENTUM OF KAYA
KAYA vs SENSEX
DEBT OF KAYA
| Year | Debt/Equity ratio | |
|---|---|---|
| Standalone | Consolidated | |
|
2024 2023 2022 Avg_3yrs |
-1.06 7.03 0.88 2.28 |
-0.78 -1.33 -30.33 -10.81 |
|
[Last Annual Data : Mar2024]
|
||
| Financial Ratios → | ||
PLEDGED PROMOTER SHARES OF KAYA
| Pledged Promoter Shares |
0 % | |
|---|---|---|
| As on : Mar2025 | ||
If less than 25% | Good |
|
| If between 25% and 50% | Neutral | |
| If greater than 50% | Bad | |
| Shareholding Pattern → | ||
QTRLY RESULTS OF KAYA
| Consolidated | Q-o-Q | Y-o-Y |
|---|---|---|
|
Revenue Op Profit Profit Before Tax Profit After Tax |
-5.9% -64.11% 1.92% 1.92% |
5.52% 102.61% 85.95% 85.95% |
| QtrlyTrend |
4 | |
| Latest Qtr: Mar2025 | ||
| Quarterly Result Analysis → | ||
KAYA related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about KAYA
Is KAYA good for long term investment?
As on Jun 10,2025, the Fundamentals of KAYA look Poor and hence it may not be good for long term investment ! See Financial Performance of KAYA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is KAYA UnderValued or OverValued?
As on Jun 10,2025, KAYA is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of KAYA ?
As on Jun 10,2025, the Intrinsic Value of KAYA is Rs. 275.14 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 275.14
Fair Value [Median EV / Sales Model] : Rs. 213.66
Fair Value [Median Price / Sales Model] : Rs. 300.54
Estimated Median Fair Value of KAYA : Rs. 275.14
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
